Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.

Jie ZhaoLu WangAnda ZhouShidi WenWenfeng FangLi ZhangJianchun DuanHua BaiJia ZhongRui WanBoyang SunWei ZhuangYiwen LinDanming HeLina CuiZhijie WangJie Wang

Published in: Med (New York, N.Y.) (2024)

This study was supported by the National Key R&D Program of China.

Keyphrases

quality improvement
squamous cell carcinoma
locally advanced
decision making
radiation therapy